Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brilinta
Pharma
BMJ finds more irregularities in trial data for AZ's Brilinta
Fourteen years after AstraZeneca’s Brilinta reached the market, the data that backed its original approvals has been called into question.
Kevin Dunleavy
Jun 23, 2025 11:33am
A closer look at pharma’s top patent losses in 2025
Mar 21, 2025 9:00am
The top 10 drugs losing US exclusivity in 2025
Mar 17, 2025 3:00am
AZ adds heart attack survivor portraits taken by Bob Harper
Nov 12, 2021 8:00am
ESC says SGLT2s like Farxiga are first-line treatment in HF
Aug 28, 2021 1:35pm
AstraZeneca's Brilinta wins FDA nod for stroke patients
Nov 6, 2020 11:18am
